Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer
Pegram, Mark D, Borges, Virginia F, Ibrahim, Nuhad, Fuloria, Jyotsna, Shapiro, Charles, Perez, Susan, Wang, Karen, Schaedli Stark, Franziska, Courtenay Luck, Nigel
Published in Breast cancer research : BCR (01.01.2009)
Published in Breast cancer research : BCR (01.01.2009)
Get full text
Journal Article
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
Walter, Harriet S., Rule, Simon A., Dyer, Martin J.S., Karlin, Lionel, Jones, Ceri, Cazin, Bruno, Quittet, Philippe, Shah, Nimish, Hutchinson, Claire V., Honda, Hideyuki, Duffy, Kevin, Birkett, Joseph, Jamieson, Virginia, Courtenay-Luck, Nigel, Yoshizawa, Toshio, Sharpe, John, Ohno, Tomoya, Abe, Shinichiro, Nishimura, Akihisa, Cartron, Guillaume, Morschhauser, Franck, Fegan, Christopher, Salles, Gilles
Published in Blood (28.01.2016)
Published in Blood (28.01.2016)
Get full text
Journal Article
Plasma Membrane Nucleolin Is a Receptor for the Anticancer Aptamer AS1411 in MV4-11 Leukemia Cells
Soundararajan, Sridharan, Wang, Li, Sridharan, Vijayalakshmi, Chen, Weiwei, Courtenay-Luck, Nigel, Jones, David, Spicer, Eleanor K, Fernandes, Daniel J
Published in Molecular pharmacology (01.11.2009)
Published in Molecular pharmacology (01.11.2009)
Get full text
Journal Article
Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity
Kwok, Hang Fai, Buick, Richard J, Kuehn, Diana, Gormley, Julie A, Doherty, Declan, Jaquin, Thomas J, McClurg, Angela, Ward, Claire, Byrne, Teresa, Jaworski, Jacob, Leung, Ka Lai, Snoddy, Philip, McAnally, Christine, Burden, Roberta E, Gray, Breena, Lowry, Jenny, Sermadiras, Isabelle, Gruszka, Natalia, Courtenay-Luck, Nigel, Kissenpfennig, Adrien, Scott, Christopher J, Johnston, James A, Olwill, Shane A
Published in Molecular cancer (14.12.2011)
Published in Molecular cancer (14.12.2011)
Get full text
Journal Article
Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide
SIVOLAPENKO, G. B, SKARLOS, D, PECTASIDES, D, STATHOPOULOU, E, MILONAKIS, A, SIRMALIS, G, STUTTLE, A, COURTENAY-LUCK, N. S, KONSTANTINIDES, K, EPENETOS, A. A
Published in European journal of nuclear medicine (01.10.1998)
Published in European journal of nuclear medicine (01.10.1998)
Get full text
Journal Article
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy
KOSMAS, C, SNOOK, D, GOODEN, C. S, COURTENAY-LUCK, N. S, MCCALL, M. J, MEARES, C. F, EPENETOS, A. A
Published in Cancer research (Chicago, Ill.) (15.02.1992)
Get full text
Published in Cancer research (Chicago, Ill.) (15.02.1992)
Journal Article
Analysis of the kappa light chain variable region in multiple myeloma
Kosmas, C, Viniou, N A, Stamatopoulos, K, Courtenay-Luck, N S, Papadaki, T, Kollia, P, Paterakis, G, Anagnostou, D, Yataganas, X, Loukopoulos, D
Published in British journal of haematology (01.08.1996)
Published in British journal of haematology (01.08.1996)
Get more information
Journal Article
Production and binding analyses of a humanised scFv against a cryptic epitope on tumour-associated fibronectin
Johdi, Nor Adzimah, Harman, Ruth, Sanjuan, Irene, Kousparou, Christina, Courtenay-Luck, Nigel, Deonarain, Mahendra P.
Published in Protein expression and purification (01.03.2013)
Published in Protein expression and purification (01.03.2013)
Get full text
Journal Article
The Bruton’s Tyrosine Kinase (BTK) Inhibitor ONO-4059: Promising Single Agent Activity and Well Tolerated in Patients with High Risk Chronic Lymphocytic Leukaemia (CLL)
Fegan, Christopher, Bagshawe, Joanne, Salles, Gilles, Karlin, Lionel, Rule, Simon, Shah, Nimish, Morschhauser, Franck, Terriou, Louis, Dyer, Martin JS, Walter, Harriet, Hutchinson, Claire, Cartron, Guillaume, Sharpe, John, Duffy, Kevin, Nishimura, Akhisa, Abe, Shin-ichiro, Honda, Hideyuki, Yasuhiro, Tomoko, Yoshizawa, Toshio, Birkett, Joseph, Courtenay-Luck, Nigel
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models
Lo, Kin-Ming, Lan, Yan, Lauder, Scott, Zhang, Jinyang, Brunkhorst, Beatrice, Qin, Guozhong, Verma, Rakesh, Courtenay-Luck, Nigel, Gillies, Stephen D
Published in Cancer Immunology, Immunotherapy (01.04.2007)
Published in Cancer Immunology, Immunotherapy (01.04.2007)
Get full text
Journal Article
Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors
COURTENAY-LUCK, N. S, EPENETOS, A. A, WINEARLS, C. G, RITTER, M. A
Published in Cancer research (Chicago, Ill.) (15.08.1987)
Get full text
Published in Cancer research (Chicago, Ill.) (15.08.1987)
Journal Article
Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms
COURTENAY-LUCK, N. S, EPENETOS, A. A, MOORE, R, LARCHE, M, PECTASIDES, D, DHOKIA, B, RITTER, M. A
Published in Cancer research (Chicago, Ill.) (01.12.1986)
Get full text
Published in Cancer research (Chicago, Ill.) (01.12.1986)
Journal Article
Cyclic AMP: A Mitogenic Signal for Swiss 3T3 Cells
Rozengurt, Enrique, Legg, Ann, Strang, George, Courtenay-Luck, Nigel
Published in Proceedings of the National Academy of Sciences - PNAS (01.07.1981)
Published in Proceedings of the National Academy of Sciences - PNAS (01.07.1981)
Get full text
Journal Article